Boosting outcomes in Stage II parapneumonic effusions with streptokinase: A randomized controlled trial

This is the authors' abstract. We don't add key points for this paper.

thickening result in a fibrous peel that may trap the lung and often necessitates surgical intervention 3 .Management of Stage II PPE remains challenging due to fibrin membranes that compartmentalize pleural fluid, impeding effective drainage 4 .Intrapleural fibrinolytics, such as streptokinase (SK), aim to dissolve these membranes, enhancing fluid clearance and potentially reducing the need for surgery 5 .Early studies, like Bergh et al. 5 , reported radiological improvements with SK in empyema patients, while Diacon et al. 6 found it safe and effective, reducing surgical referrals 6 .However, conflicting results, such as those from the MIST1 trial showing no benefit 7 , underscore the need for further investigation.The findings may be relevant to resource-limited settings, although further studies are needed to evaluate the economic implications of intrapleural streptokinase.